Sigilon Therapeutics
Biotechnology Research · 51 Employees
Phone Number: 6173367540
Email Address: info@sigilon.com
- Overview
- Employees
Access 51 Verified Employees Profiles for Sigilon TherapeuticsUnlock Free Contacts Now
About
Sigilon Therapeutics', a wholly owned subsidiary of Eli Lilly and Company, mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases. We're based in Cambridge, Mass.
Website
Year Founded
2015
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research
HQ Location
100 Binney St, STE 600
STE 2C
Cambridge, MA 02142, US
Keywords
cell therapybiotechnologyhemophiliadiabeteslysosomal storage disordersbiocompatible materialschronic diseasesand cell engineering
Location
- 100 Binney St, STE 600 STE 2C Cambridge, MA 02142, US
Email Formats
Sign up for free credits and discover verified email addresses of Sigilon Therapeutics
FormatExamples
first + last
andywarhol@sigilon.com
first_initial + last
awarhol@sigilon.com
first + last_initial
andyw@sigilon.com
first
andy@sigilon.com
last
warhol@sigilon.com
Frequently Asked Questions
Key Contacts
Similar Companies
Biotechnology Research
Get key business info for Sigilon Therapeutics and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.